(Not available in CA)
Fan JX, Deng RH, Wang H, et al
1 That result is comparable to injectable Wegovy 2.4 mg, which achieved 14.9% weight loss in the STEP 1 trial
These events were captured through chart documentation and diagnostic coding during follow-up
Gastroparesis, pancreatitis, thyroid, the potential for thyroid cancer, which Ill hit on, and gallbladder issues
We are also recommending that if patients are starting these drugs or increasing the dose of these drugs, they should do so slowly to reduce the risk of dropping their blood sugar and causing an osmotic shift. Bradley Katz, MD, PhD We as well as other concerned physicians are also asking FDA to mandate a post-marketing survey of these drugs to find the true incidence of eye complications associated with them